Schaule, Jana https://orcid.org/0000-0001-5870-0980
Kroeze, Stephanie G. C.
Blanck, Oliver
Stera, Susanne
Kahl, Klaus H.
Roeder, Falk
Combs, Stephanie E.
Kaul, David
Claes, An
Schymalla, Markus M.
Adebahr, Sonja
Eckert, Franziska
Lohaus, Fabian
Abbasi-Senger, Nasrin
Henke, Guido
Szuecs, Marcella
Geier, Michael
Sundahl, Nora
Buergy, Daniel
Dummer, Reinhard
Guckenberger, Matthias
Funding for this research was provided by:
Varian Medical Systems (NA)
Article History
Received: 12 April 2020
Accepted: 1 May 2020
First Online: 1 June 2020
Change Date: 14 December 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Ethics approval was obtained by the lead ethics committee in Zurich (BASEC-Nr. 2016–01807) and from all participating centers at their local ethics committees. All patients signed consent forms.
: NA
: NS: travel grants from Merck Sharpe & Dohme, Astellas, Bayer and Bristol-Myers-Squibb. DB reports personal fees from Siemens AG, personal fees from NB Capital Research GmbH, personal fees from NB Capital ApS, personal fees from b.e. Imaging GmbH outside the submitted work. MS: remuneration for lectures from Merck Serono and AstraZeneca.All other authors declare no conflicts of interest.